Infantile Krabbe disease (0-12 months), progression, and recommended endpoints for clinical trials.

MLA

Greco, Melissa R., et al. “Infantile Krabbe Disease (0-12 Months), Progression, and Recommended Endpoints for Clinical Trials.” Annals of Clinical and Translational Neurology, Nov. 2024. EBSCOhost, https://doi.org/10.1002/acn3.52114.

APA

Greco, M. R., Lopez, M. A., Beltran-Quintero, M. L., Tuc Bengur, E., Poe, M. D., & Escolar, M. L. (2024). Infantile Krabbe disease (0-12 months), progression, and recommended endpoints for clinical trials. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52114

Chicago

Greco, Melissa R, Mabel A Lopez, Maria L Beltran-Quintero, Ecenur Tuc Bengur, Michele D Poe, and Maria L Escolar. 2024. “Infantile Krabbe Disease (0-12 Months), Progression, and Recommended Endpoints for Clinical Trials.” Annals of Clinical and Translational Neurology, November. doi:10.1002/acn3.52114.